1·Conclusion Deanxit and rabeprazole on functional dyspepsia and maintenance treatment of recent have a good effect, no significant adverse reactions, is worthy of clinical use.
结论黛力新与雷贝拉唑对功能性消化不良的近期及维持治疗均有良好疗效，无明显不良反应，值得临床推广使用。
2·Rabeprazole is a new type of Proton Pump Inhibitors, which is widely used in therapy for digestive system illness.
雷贝拉唑是一种新型的质子泵抑制剂，广泛应用于消化系统疾病的治疗。